Navigation Links
STAAR Surgical to Present at the Noble Financial Equity Conference
Date:8/11/2008

MONROVIA, Calif., Aug. 11 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, announced today that it will present at the at the upcoming Fourth Annual Noble Financial Equity Conference which will be held Monday, August 18th - Tuesday, August 19th, 2008 at the Loews Lake Las Vegas Resort, Nevada. Barry G. Caldwell, President and Chief Executive Officer will discuss the Company's business strategy and historical financial performance at 11:00 a.m. Pacific Time on Monday, August 18th.

A live audio webcast of STAAR Surgical's presentation may be accessed through the Company's website at http://www.staar.com. The presentation will feature high-definition, streaming video and PowerPoint slides. It is recommended that interested parties register 15 minutes prior to the start of the presentation to ensure timely access. An archived replay of the presentation will be available after the live presentation, and can also be accessed at http://www.staar.com.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. Collamer(R) is the brand name for STAAR's proprietary collagen copolymer lens material. More information is available at http://www.staar.com.

CONTACT: Investors Media

EVC Group EVC Group

Dahlia Bailey, 415-896-5862 Steve DiMattia 646-201-5445


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. STAAR Surgicals Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification
2. STAAR Surgicals LASIK Alternative Expands U.S. Market Gains
3. STAAR Surgical Reports Solid First Quarter Progress
4. STAAR Surgical Announces First Quarter 2008 Earnings Release Date and Conference Call
5. STAAR Surgical Plans Major Presence at ASCRS
6. STAAR Surgical Reports Fourth Quarter and Year End Results
7. STAAR Surgicals Visian ICL Procedure Performed Live on NBCs Today show
8. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
9. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
10. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
11. STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Texas (PRWEB) , ... January 19, 2017 , ... Students ... GenCure Tissue Donation Awareness Scholarship competition., The winner will earn a $1,000 scholarship and ... The competition begins Feb. 1, and the deadline is May 31, with the winner ...
(Date:1/19/2017)... Pittsburgh, PA (PRWEB) , ... January 19, 2017 , ... ... the experience of patients who seek access to the Network’s programs and services in ... requesting primary or specialty care appointments will be offered one for that same afternoon. ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the third ... New Jersey and the surrounding area, is inaugurating a charity event to ... commonly known as Lou Gehrig's disease or motor neurone disease, is a deadly ...
(Date:1/19/2017)... CT (PRWEB) , ... January 19, 2017 , ... ... certified Reproductive Endocrinologists at Reproductive Medicine Associates of Connecticut (RMACT) have earned ... Dr. Cynthia Murdock and Dr. Shaun Williams have each been chosen by their ...
(Date:1/19/2017)... VA (PRWEB) , ... January 19, 2017 , ... The ... Thrive in 2017, **An FDAnews Webinar**, Jan. 26, 2016 — 1:30 p.m. – 3:00 ... about the 21st Century Cures Act in order to thrive this year? , The ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Jan. 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ... mitochondrial dysfunction, today announced new additions to its senior ... Chief Medical Officer, and Daniel Geffken as ... Jim Carr , Pharm.D. has been promoted to ... pleased to welcome Doug and Daniel to our management ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017  Abaxis, Inc. ... manufacturing point-of-care blood analysis instruments and consumables for the ... call to discuss its financial results for the third ... call will be at 4:15 p.m. ET on Thursday, ... for the third quarter fiscal year 2017 after the ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
Breaking Medicine Technology: